Applications

Infliximab on bioZen 1.8 µm SEC-3

Analytes

1Infliximab

Analyte not found

Details

LC Conditions (App ID: 24764)

Column:

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Brand Name:

bioZen

Part No:

00H-4772-E0

Phase Name:

SEC-3

Elution Type:

Isocratic

Mobile Phase:

A: 50 mM K2PO4 100 mM Na2SO4, pH 6

Gradient Profile:

Step No.	Time(min)	%A
1	30	100

Flow Rate:

0.2 mL/min

Temperature:

25°C

Detection:

UV-Vis Abs.-Variable Wave.(UV) @ 280 nm (25°C)

Order Items Used in This Application

00H-4772-E0

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Qty:

infoSign in to view country specific pricing

Similar Applications

Select Analyte of Interest

Infliximab Peptide Mapping with Tryptic Digest on bioZen 1.6 µm Peptide PS-C18

bioZen 1.6 µm Peptide PS-C18, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Infliximab Peptide Mapping with Tryptic Digest on bioZen 2.6 µm Peptide XB-C18

bioZen 2.6 µm Peptide XB-C18, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Infliximab-dyyb Triplicate Injections on bioZen 1.8 um SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Infliximab-abda on bioZen SEC-3

bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea

Gel Filtration Chromatography (GFC)

Inflixmab F(ab)2 80°

bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Inflixmab F(ab)2 80°

bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea

Reversed Phase

Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.

CONNECT WITH US

PRODUCTS AND SERVICES

SUPPORT

Product/Method Support

Product Troubleshooting

OUR COMPANY

Danaher Life Sciences

Applications

Infliximab on bioZen 1.8 µm SEC-3

Order Items Used in This Application

App ID 24764

Order Items Used in This Application